Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1
HAD-B1 is a Korean herbal formula designed to treat solid tumors, and through cell experiments, it has proven to have an anticancer effect. The current study aims to test the safety of HAD-B1. This experiment is under the regulation of ICH. In order to find if HAD-B1 has any effect on the CNS, 0, 50...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Hindawi Limited
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/3aa9d6a638064f50a1c591ce8fa13361 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|